Skip to content

Effects of Hemoperitoneum Driven Carbon Monoxide on Post-Traumatic Stability and Platelet Aggregation

Effects of Hemoperitoneum Driven Carbon Monoxide on Post-Traumatic Stability

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01594034
Enrollment
9
Registered
2012-05-08
Start date
2009-11-30
Completion date
2011-05-31
Last updated
2012-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemoperitoneum

Brief summary

Our objective is to determine whether or not the presence of hemoperitoneum in trauma patients is associated with increased Carbon Monoxide (CO) formation, and to determine if elevated Carbon Monoxide levels are associated with cardiovascular depression, impaired platelet aggregation, and/or multiple organ failure.

Interventions

PROCEDUREexpired air

collection of expired air from ventilator

Sponsors

The University of Texas Health Science Center at San Antonio
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Hospitalized males 18 years of age or older, 2. Diagnosis of isolated blunt OR blunt and penetrating trauma, 3. Admitted or expecting to be admitted to the Intensive Care Unit, 4. On mechanical ventilation, and 5. Written informed consent obtained

Exclusion criteria

1. Female gender, (Females will be excluded from this study as the menstrual cycle and other estrogen variations are known to be associated with cyclic changes in CO production adding a potential confounder to the interpretations of our findings.) 2. Diagnosis of isolated penetrating trauma, 3. Acute hemothorax or pneumothorax, 4. Treatment with antiaggregants (ASA, clopidogrel, aggrenox or ticlopidine), 5. Enrollment in another research study, 6. Prisoners, 7. Inability to perform CO measurement within 96 hours after hospital admission.

Design outcomes

Primary

MeasureTime frame
•Establish a method for reliably measuring CO excretion in patients.96 hours

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026